Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History $1.34 -0.03 (-1.82%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.34%, with a year-to-date return of 5.08%. In the past month, the stock has decreased 3.93%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at $1.37 with a market cap of $113.23 million and volume of 237,795 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.28%1 Month Performance-3.93%3 Month Performance+40.54%Year-To-Date Performance+5.08%1 Year Performance-35.34% CRDL Stock Chart for Friday, July, 11, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/10/2025$1.39$1.37-1.44%$1.39$1.31237,795 shs$113.23 million07/09/2025$1.40$1.39-0.71%$1.40$1.35168,404 shs$114.88 million07/08/2025$1.45$1.40-3.45%$1.50$1.36236,532 shs$115.71 million07/07/2025$1.52$1.45-4.35%$1.53$1.42216,997 shs$127.28 million07/04/2025$1.52$1.52$1.54$1.42368,415 shs$125.30 million07/03/2025$1.39$1.52+9.06%$1.54$1.42368,415 shs$125.30 million07/02/2025$1.32$1.39+5.30%$1.41$1.30203,808 shs$114.88 million07/01/2025$1.36$1.32-2.94%$1.40$1.30143,822 shs$109.10 million06/30/2025$1.41$1.36-3.55%$1.42$1.32209,951 shs$112.40 million06/27/2025$1.47$1.41-4.08%$1.50$1.4072,055 shs$116.54 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/26/2025$1.45$1.47+1.38%$1.49$1.41142,827 shs$121.50 million06/25/2025$1.34$1.45+8.21%$1.48$1.35395,411 shs$119.84 million06/24/2025$1.28$1.34+4.69%$1.36$1.29126,875 shs$110.75 million06/23/2025$1.24$1.28+3.23%$1.32$1.24162,865 shs$105.79 million06/20/2025$1.32$1.24-6.06%$1.37$1.22291,778 shs$102.49 million06/19/2025$1.32$1.32$1.37$1.31183,965 shs$109.10 million06/18/2025$1.37$1.32-3.65%$1.37$1.31183,965 shs$109.10 million06/17/2025$1.43$1.37-4.20%$1.44$1.36194,617 shs$113.23 million06/16/2025$1.46$1.43-2.05%$1.49$1.42114,519 shs$118.19 million06/13/2025$1.44$1.46+1.39%$1.50$1.38177,007 shs$120.67 million06/12/2025$1.40$1.44+2.86%$1.45$1.35289,748 shs$119.02 million06/11/2025$1.45$1.40-3.45%$1.45$1.39171,860 shs$115.71 million06/10/2025$1.44$1.45+0.69%$1.49$1.40347,819 shs$119.84 million Related Companies ORGO Stock Price Chart SIGA Stock Price Chart CGEM Stock Price Chart ATYR Stock Price Chart KMDA Stock Price Chart ATAI Stock Price Chart TRML Stock Price Chart MREO Stock Price Chart RGNX Stock Price Chart PGEN Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRDL) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
